Literature DB >> 12410315

Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota.

Ahmad Faili1, Said Aoufouchi, Eric Flatter, Quentin Guéranger, Claude-Agnès Reynaud, Jean-Claude Weill.   

Abstract

Somatic hypermutation of immunoglobulin genes is a unique, targeted, adaptive process. While B cells are engaged in germinal centres in T-dependent responses, single base substitutions are introduced in the expressed Vh/Vl genes to allow the selection of mutants with a higher affinity for the immunizing antigen. Almost every possible DNA transaction has been proposed to explain this process, but each of these models includes an error-prone DNA synthesis step that introduces the mutations. The Y family of DNA polymerases--pol eta, pol iota, pol kappa and rev1--are specialized for copying DNA lesions and have high rates of error when copying a normal DNA template. By performing gene inactivation in a Burkitt's lymphoma cell line inducible for hypermutation, we show here that somatic hypermutation is dependent on DNA polymerase iota.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410315     DOI: 10.1038/nature01117

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  64 in total

1.  Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.

Authors:  Brian S Majors; Gisela G Chiang; Nels E Pederson; Michael J Betenbaugh
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

2.  A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.

Authors:  Xiaoping Wu; Connie Y Tsai; Marienida B Patam; Hong Zan; Jessica P Chen; Steve M Lipkin; Paolo Casali
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

3.  Germinal center-associated nuclear protein contributes to affinity maturation of B cell antigen receptor in T cell-dependent responses.

Authors:  Kazuhiko Kuwahara; Satoru Fujimura; Yoshimasa Takahashi; Naomi Nakagata; Toshitada Takemori; Shinichi Aizawa; Nobuo Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

4.  Genome-wide somatic hypermutation.

Authors:  Clifford L Wang; Ryan A Harper; Matthias Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-29       Impact factor: 11.205

5.  Sequence similarities of protein kinase substrates and inhibitors with immunoglobulins and model immunoglobulin homologue: cell adhesion molecule from the living fossil sponge Geodia cydonium. Mapping of coherent database similarities and implications for evolution of CDR1 and hypermutation.

Authors:  J Kubrycht; J Borecký; P Soucek; P Jezek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation.

Authors:  Hong Zan; Naoko Shima; Zhenming Xu; Ahmed Al-Qahtani; Albert J Evinger Iii; Yuan Zhong; John C Schimenti; Paolo Casali
Journal:  EMBO J       Date:  2005-10-13       Impact factor: 11.598

Review 7.  DNA polymerases and somatic hypermutation of immunoglobulin genes.

Authors:  Mineaki Seki; Patricia J Gearhart; Richard D Wood
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

Review 8.  DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation.

Authors:  Zhenming Xu; Zsolt Fulop; Yuan Zhong; Albert J Evinger; Hong Zan; Paolo Casali
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

9.  Involvement of Rad18 in somatic hypermutation.

Authors:  Jürgen Bachl; Isin Ertongur; Berit Jungnickel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

10.  Mutations occur in the Ig Smu region but rarely in Sgamma regions prior to class switch recombination.

Authors:  Carol E Schrader; Sean P Bradley; Joycelyn Vardo; Sofia N Mochegova; Erin Flanagan; Janet Stavnezer
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.